XML 45 R28.htm IDEA: XBRL DOCUMENT
v3.21.2

Common Stock, Stock Options and Warrants (Details) - USD ($) |  |  |  |  |  |  |  |  |  | 1 Months Ended | 12 Months Ended |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Feb. 12, 2021 | Sep. 08, 2020 | Aug. 10, 2020 | Jun. 26, 2020 | Apr. 06, 2020 | Feb. 10, 2020 | Jan. 31, 2020 | Dec. 31, 2019 | Nov. 04, 2019 | Feb. 19, 2021 | Jan. 27, 2021 | May 18, 2020 | Feb. 14, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Jun. 21, 2021 | May 24, 2021 | Apr. 30, 2021 | Nov. 05, 2020 | Feb. 07, 2018
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common shares authorized |  |  |  |  |  |  |  |  |  |  |  |  |  | 400,000,000 | 400,000,000 |  |  |  |  |
Common stock, shares issued | 50,000 | 101,174 |  |  | 50,000 | 150,000 |  |  | 186,566 |  |  |  |  |  |  |  |  |  |  |
Fair value of common stock issued (in Dollars) | $ 68,000 | $ 100,000 |  |  | $ 22,750 | $ 306,020 |  |  | $ 100,000 |  |  |  |  |  |  |  |  |  |  |
Common stock for general advisory and business development advisory services |  |  |  |  |  | 136,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common shares reserved |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,000,000 |
Shares available for future grants |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,530,000 |  |  |  |  |  |
Weighted average grant date fair value (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.34 | $ 0.76 |  |  |  |  |
Options vest over terms |  |  |  |  |  |  |  |  |  |  |  |  |  | 10 years | 10 years |  |  |  |  |
Stock-based compensation expense description |  |  |  |  |  |  |  |  |  |  |  |  |  | Stock-based compensation expense for the years ended September 30, 2021 and 2020 was $1,454,979 (including $83,555 for the NoveCite Stock Plan) and $803,261, respectively. |  |  |  |  |  |
Citius stock plans (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,012,685 |  |  |  |  |  |
Weighted average period term |  |  |  |  |  |  |  |  |  |  |  |  |  | 2 years 4 months 2 days |  |  |  |  |  |
Common shares outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,000,000 |  |  |  |  |  |
Stock option purchase grants |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,000,000 |  |  |  |  |  |
Weighted average exercise price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.24 |  |  |  |  |  |
Weighted average grant date fair value description |  |  |  |  |  |  |  |  |  |  |  |  |  | The weighted average grant date fair value of the options granted during the year ended September 30, 2021 was estimated at $0.20 per share. All of these options vest over 36 months and have a term of 10 years. The weighted average remaining contractual term of options outstanding under the NoveCite Stock Plan is 9.39 years. At September 30, 2021, unrecognized total compensation cost related to unvested awards under the NoveCite Stock Plan of $316,445 is expected to be recognized over a weighted average period of 2.42 years. |  |  |  |  |  |
Warrants were exercised (in Dollars per share) |  |  |  | $ 1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds (in Dollars) |  |  |  | $ 1,129,412 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercise agreement description |  |  |  |  |  |  |  |  |  |  |  |  | the Company entered into a warrant exercise agreement for an aggregate of 3,712,218 shares of common stock having an existing exercise price of $0.77 and 2,586,455 shares of common stock at a reduced exercise price of $1.02. In consideration for the exercise of the warrants for cash, the exercising holders received new unregistered warrants to purchase 6,298,673 shares of common stock at an exercise price of $1.02 per share, exercisable six months after issuance and which have a term of exercise equal to five years. The offering closed on February 19, 2020 and net proceeds were $5,013,930 after placement agent fees and offering expenses. The Company also issued warrants to purchase 440,907 shares to the placement agent. The placement agent warrants have identical terms to the investor warrants except that the exercise price is $1.275 per share. The estimated fair value of the 6,298,673 warrants issued to the investors was $5,360,465 and the estimated fair value of the 440,907 warrants issued to the placement agent was $367,022. |  |  |  |  |  |  |
Extended term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years |  |
Extented date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Apr. 05, 2024 |  |
Warrants for common stock |  |  |  |  |  |  |  |  |  |  |  |  |  | 145,979,429 | 55,576,996 |  |  | 1,294,498 |  |
Common stock exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.42 |  |
Warrants shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 240,130 |  |
Warrants exercise price per share (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.93 |  |
Fair value of deemed dividend (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,450,876 |  |  |  |  |  |
Proceeds from exercise of common stock warrants (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 31,130,134 |  |  |  |  |  |
Registered Direct Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of warrants |  |  |  |  |  |  |  |  |  |  |  | the Company closed a registered direct offering with several institutional and accredited investors for the sale of 7,058,824 shares of common stock at $1.0625 per share for gross proceeds of $7,500,001. The Company also issued 3,529,412 unregistered immediately exercisable warrants to the investors with an exercise price of $1.00 per share and a term of five and one-half years. The Company paid the placement agent for the offering a fee of 7% of the gross proceeds totaling $525,000 and issued the placement agent 494,118 immediately exercisable warrants with an exercise price of $1.3281 per share and a term of five years. The Company also reimbursed the placement agent for $85,000 in expenses and incurred $12,901 in other expenses. Net proceeds from the offering were $6,877,100. The estimated fair value of the 3,529,412 warrants issued to the investors was $2,138,998 and the estimated fair value of the 494,118 warrants issued to the placement agent was $275,724. |  |  |  |  |  |  |  |
Common stock offerings, description |  |  |  |  |  |  |  |  |  | the Company closed a registered direct offering for 50,830,566 common shares and warrants to purchase up to 25,415,283 common shares, at a purchase price of $1.505 per share of common stock and accompanying warrant, for gross proceeds of $76,500,002. The 25,415,283 warrants are immediately exercisable at $1.70 per common share for a term of five years. The Company paid the placement agent a fee of 7% of the gross proceeds totaling $5,355,000 and issued the placement agent 3,558,140 immediately exercisable warrants at $1.881 per common share for a term of five years. The Company also reimbursed the placement agent for $85,000 in expenses and incurred $80,160 in other expenses. Net proceeds from the offering were $70,979,842. The estimated fair value of the 25,415,283 warrants issued to the investors was approximately $42,322,000 and the estimated fair value of the 3,558,140 warrants issued to the placement agent was approximately $5,850,000. |  |  |  |  |  |  |  |  |  |
Underwritten Public Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of warrants |  |  | the Company closed an underwritten public offering of 9,159,524 shares of common stock at a price of $1.05 per share for gross proceeds of $9,617,500. The Company paid the underwriter a fee of 7% of the gross proceeds totaling $673,225 and issued the underwriters 641,166 immediately exercisable warrants with an exercise price of $1.3125 per share and a term of five years. The Company also reimbursed the placement agent for $135,000 in expenses and incurred $109,074 in other expenses. Net proceeds from the offering were $8,700,201. The estimated fair value of the 641,166 warrants issued to the underwriter was $569,426. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
2014 Stock Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock for issuance |  |  |  |  |  |  |  |  |  |  |  |  |  | 866,667 |  |  |  |  |  |
Shares outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  | 855,171 |  |  |  |  |  |
Purchase of shares were exercised |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,829 |  |  |  |  |  |
Options to purchase shares expired |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,667 |  |  |  |  |  |
2018 Omnibus Stock Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock for issuance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,000,000
2020 Omnibus Stock Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of shares were exercised |  |  |  |  |  |  |  |  |  |  |  |  |  | 70,000 |  |  |  |  |  |
Number of shares outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,820,000 |  |  |  |  |  |
Remaining shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 110,000 |  |  |  |  |  |
2020 Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common shares reserved |  |  |  |  |  | 3,110,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
2021 Omnibus Stock Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Remaining shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,240,000 |  |  |  |  |  |
Option to purchase share outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,870,000 |  |  |  |  |  |
2021 Stock Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common shares reserved |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8,740,000 |  |  |
Option to purchase share outstanding |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,210,000 |  |  |  |  |  |
Shares available for future grants |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,530,000 |  |  |  |  |  |
Stock Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Contractual term |  |  |  |  |  |  |  |  |  |  |  |  |  | 10 years |  |  |  |  |  |
September 2019 Offering Pre-Funded [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants shares |  |  |  |  |  |  |  | 1,060,615 |  |  |  |  |  |  |  |  |  |  |  |
Warrants were exercised (in Dollars per share) |  |  |  |  |  |  |  | $ 0.0001 |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds (in Dollars) |  |  |  |  |  |  |  | $ 106 |  |  |  |  |  |  |  |  |  |  |  |
September 2019 Offering Investor [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants shares |  |  |  |  |  |  | 1,315,715 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants were exercised (in Dollars per share) |  |  |  |  |  |  | $ 0.77 |  |  |  |  |  |  |  |  |  |  |  |  |
Net proceeds (in Dollars) |  |  |  |  |  |  | $ 1,013,101 |  |  |  |  |  |  |  |  |  |  |  |  |
May 2020 Registered Direct Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants shares |  |  |  | 1,129,412 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares of capital stock authorized |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 210,000,000 |  |  |  |
Common shares authorized |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 200,000,000 |  |  |  |
Options vest over terms |  |  |  |  |  |  |  |  |  |  |  |  |  | 12 months | 12 months |  |  |  |  |
Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares of capital stock authorized |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 410,000,000 |  |  |  |
Common shares authorized |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 400,000,000 |  |  |  |
Options vest over terms |  |  |  |  |  |  |  |  |  |  |  |  |  | 36 months | 36 months |  |  |  |  |
Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common shares reserved |  |  |  |  |  |  |  |  |  |  |  |  |  | 40,208,347 |  |  |  |  |  |
Weighted average remaining life of the outstanding warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 8 months 26 days |  |  |  |  |  |
Aggregate intrinsic value for the warrants outstanding (in Dollars) |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 19,903,185 |  |  |  |  |  |
Private Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock, Stock Options and Warrants (Details) [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock offerings, description |  |  |  |  |  |  |  |  |  |  | the Company closed a private placement for 15,455,960 common shares and warrants to purchase 7,727,980 common shares, at a purchase price of $1.294 per common share and accompanying warrant, for gross proceeds of $20,000,012. The 7,727,980 warrants are immediately exercisable at $1.231 per common share for a term of five and one-half years. The Company paid the placement agent a fee of 7% of the gross proceeds totaling $1,400,001 and issued the placement agent 1,081,917 immediately exercisable warrants at $1.6175 per common share for a term of five and one-half years. The Company also reimbursed the placement agent for $85,000 in expenses and incurred $64,601 in other expenses. Net proceeds from the offering were $18,450,410. The estimated fair value of the 7,727,980 warrants issued to the investors was approximately $7,582,000 and the estimated fair value of the 1,081,917 warrants issued to the placement agent was approximately $1,025,000. |  |  |  |  |  |  |  |  |

X
- Definition Citius stock plans. + References No definition available. + Details
Name: | ctxr_CitiusStockPlans
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | ctxr_ClassOfWarrantOrRightTitleOfSecurityWarrantOrRightsOutstanding
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Common shares outstanding. + References No definition available. + Details
Name: | ctxr_CommonSharesOutstanding
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Common stock exercise price per share. + References No definition available. + Details
Name: | ctxr_CommonStockExercisePricePerShare
Namespace Prefix: | ctxr_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Common stock for general advisory and business development advisory services. + References No definition available. + Details
Name: | ctxr_CommonStockForGeneralAdvisoryAndBusinessDevelopmentAdvisoryServices
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_CommonStockIssuedShares
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | ctxr_CommonStockOfferingsDescription
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_CommonStockStockOptionsandWarrantsDetailsLineItems
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Net proceeds. + References No definition available. + Details
Name: | ctxr_NetProceeds
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Option to purchase share outstanding. + References No definition available. + Details
Name: | ctxr_OptionToPurchaseShareOutstanding
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Stock option purchase grants. + References No definition available. + Details
Name: | ctxr_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentGranted
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | ctxr_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4
Namespace Prefix: | ctxr_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. + References No definition available. + Details
Name: | ctxr_SharebasedCompensationArrangementSharebasedPaymentAwardOptionsExercisableIntrinsicValue
Namespace Prefix: | ctxr_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Stock options vest over terms. + References No definition available. + Details
Name: | ctxr_StockOptionsVestOverTerms
Namespace Prefix: | ctxr_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock-based compensation expense description. + References No definition available. + Details
Name: | ctxr_StockbasedCompensationExpenseDescription
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description warrant exercise agreement. + References No definition available. + Details
Name: | ctxr_WarrantExerciseAgreementDescription
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant shares. + References No definition available. + Details
Name: | ctxr_WarrantShares
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Warrants exercise price. + References No definition available. + Details
Name: | ctxr_WarrantsExercisePrice
Namespace Prefix: | ctxr_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Outstanding warrants to purchase of its common stock. + References No definition available. + Details
Name: | ctxr_WarrantsOutstandingPurchaseOfCommonStock
Namespace Prefix: | ctxr_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | ctxr_WeightedAverageExercisePrice
Namespace Prefix: | ctxr_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description weighted average grant date fair value. + References No definition available. + Details
Name: | ctxr_WeightedAverageGrantDateFairValueDescription
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average period. + References No definition available. + Details
Name: | ctxr_WeightedAveragePeriodTerm
Namespace Prefix: | ctxr_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section 25 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875 + Details
Name: | us-gaap_FairValueAdjustmentOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (g)(3) -URI http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 55 -Paragraph 53 -URI http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971 + Details
Name: | us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 5 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_LongTermDebtTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Net number of non-option equity instruments granted to participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3)-(4) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average grant-date fair value of options vested. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued which are neither cancelled nor held in the treasury. + References No definition available. + Details
Name: | us-gaap_SharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The fair value of stock issued in noncash financing activities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586 + Details
Name: | us-gaap_StockIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan. + References No definition available. + Details
Name: | us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_WarrantExercisePriceIncrease
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_RegisteredDirectOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_UnderwrittenPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_StockIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_TwoThousandEighteenOmnibusStockIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_TwoThousandTwentyOmnibusStockIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_TwoThousandTwentyPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_TwoThousandTwentyOneOmnibusStockIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_TwoThousandTwentyOneStockPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_SeptemberOfferingPreFundedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_SeptemberOfferingInvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=ctxr_MayRegisteredDirectOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |